Skip to main content
What types of page to search?

Alternatively use our A-Z index.

Publications

What type of publication do you want to show?

2021

Korrelation von HPV16 Genstatus und Genexpression in OPSCC

von Witzleben, A., Currall, E., Wood, O., Chudley, L., Akinyegun, O., Thomas, J., . . . Ottensmeier, C. H. (2021). Korrelation von HPV16 Genstatus und Genexpression in OPSCC. In Laryngo-Rhino-Otologie. Georg Thieme Verlag KG. doi:10.1055/s-0041-1727869

DOI
10.1055/s-0041-1727869
Conference Paper

2018

A randomised, double-blind, placebo-controlled phase IIa trial of AMG319 given orally as neoadjuvant therapy in patients with human papillomavirus (HPV) positive and negative head and neck squamous cell carcinoma (HNSCC).

Ottensmeier, C. H. H., Jones, T., Sacco, J. J., McCaul, J. A., Brennan, P., Paterson, C., . . . King, E. (2018). A randomised, double-blind, placebo-controlled phase IIa trial of AMG319 given orally as neoadjuvant therapy in patients with human papillomavirus (HPV) positive and negative head and neck squamous cell carcinoma (HNSCC).. In JOURNAL OF CLINICAL ONCOLOGY Vol. 36. doi:10.1200/JCO.2018.36.15_suppl.6068

DOI
10.1200/JCO.2018.36.15_suppl.6068
Conference Paper